Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · PGQ

Cochlear Implant With Combined Electrical Stimulation And Acoustic Amplification

Intended to provide electric stimulation to the mid to high frequency region of the cochlea and acoustic amplification to the low frequency regions, for patients with residual low frequency hearing sensitivity.

Product / regulatory recordCompanyPathwayDecision dateSource
Cochlear AmericasPMA supplementSep 28, 2026FDA
Cochlear AmericasPMA supplementApr 30, 2026FDA
Cochlear AmericasPMA supplementOct 16, 2025FDA
Cochlear AmericasPMA approvalMar 20, 2014FDA
Source information

Follow the FDA links to view the original records.

All device categories